Skip to Content

Join the 'Gammaplex' group to help and get support from people like you.

Gammaplex News

Densensitization Procedure Helps Hard-to-Match Kidney Recipients

Posted 27 Jul 2011 by Drugs.com

WEDNESDAY, July 27 – A combination therapy that "desensitizes" kidney transplant recipients could help hard-to-match patients find a needed kidney faster. The desensitization procedure combines the use of plasmapheresis – a machine that filters the blood plasma to remove antibodies – and low-doses of a medication called intravenous immune globulin (IVIG). The combination of these therapies improves survival rates dramatically. Eight years after receiving a transplant, survival rates were 81 percent for those who received the treatment compared to just 31 percent for people who had to stay on dialysis, new research found. "This is a huge unmet problem. There are probably as many as 30,000 people who have been exposed to foreign tissue waiting for a kidney. They're really hard to match," explained study author Dr. Robert Montgomery, director of the comprehensive transplant program at ... Read more

Related support groups: Renal Transplant, Gammagard, Gamunex, Privigen, Immune Globulin Intravenous, Sandoglobulin, Carimune, Polygam S/D, Gammagard S/D, Venoglobulin-S 5%, Flebogamma, Octagam, Gamimune N 10%, Panglobulin NF, Gammar-P IV, Venoglobulin-S 10%, Carimune NF, Iveegam En, Gamimune, Panglobulin

Ask a Question

Further Information

Related Condition Support Groups

Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Chronic Lymphocytic Leukemia (CLL), Idiopathic (Immune) Thrombocytopenic Purpura, Autoimmune Neutropenia, Bone Marrow Transplantation, Primary Immunodeficiency Syndrome, Evan's Syndrome, Kawasaki Disease, HIV Infection, Polymyositis / Dermatomyositis

Gammaplex Patient Information at Drugs.com